Poolbeg Pharma
  • About
    • About
    • Leadership
  • Pipeline
    • Pipeline
    • POLB 001 Oncology
    • POLB 001 Influenza
    • Oral Encapsulated GLP-1
    • AI Programmes
  • Partnering
  • Insights
  • News & Media
    • Media Coverage
    • Media Library
    • Media Press Kit
  • Investors
    • Investors
    • Regulatory News & Email Alerts
    • Share Price Information
    • Presentations & Events
    • AIM Rule 26
    • Documents
    • Advisors
    • Corporate Governance
  • Careers
  • Contact

Media Coverage

The Guardian

London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’

Jun 14, 2026
Yahoo Finance

Poolbeg Pharma has begun an exciting new clinical trial – ICYMI

Jun 13, 2026
This Is Money

SMALL CAP IDEA: Poolbeg Pharma and the oral drug that could unlock cancer immunotherapy’s biggest problem

Jun 8, 2026
Business Post

Poolbeg Pharma reports positive FDA feedback on treatment

May 25, 2026
Drug Discovery World (DDW)

Expert opinion: Navigating the challenges in the clinical trials sector

May 20, 2026
Investing.com

Poolbeg Pharma receives Canadian patent for cancer treatment

May 11, 2026
Business Post

Poolbeg Pharma gets Canadian patent approval for cancer drug

May 11, 2026
Pharma Times

Poolbeg secures Canadian patent for POLB 001 in cancer immunotherapy‑induced CRS

May 11, 2026
FirstWord Pharma

Poolbeg eyes transformative summer with POLB 001 data in prospect

Apr 30, 2026
Business Post

Poolbeg Pharma eyes partnerships as key trial data nears

Apr 29, 2026
  • Previous
  • 1
  • …
  • 1
  • 2
  • 3
  • …
  • 24
  • Next


Subscribe for RNS email alerts
  • Privacy Policy
  • Cookie Policy
Londonstockexchange Logo White 2

Traded on the London Stock Exchange | Ticker: POLB

Stay in touch



Latest Presentation

© 2026 Poolbeg Pharma

link

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Poolbeg Pharma
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Cookie Policy

More information about our Cookie Policy